Acadia Pharmaceuticals Inc. · NASDAQ:ACAD
Julian C. Baker reported a 25.40% stake in Acadia Pharmaceuticals Inc. (Schedule 13D/A)
Event Feb 24, 2026 · Filed Feb 26, 2026
Julian C. Baker reported a 25.40% stake in Acadia Pharmaceuticals Inc., 43,294,373 shares, with active intent on Feb 24, 2026. Filed Feb 26, 2026 (Schedule 13D/A).
- Stake
- 25.40%
- Shares
- 43,294,373
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 25.30% | 43,151,054 |
| Baker Bros. Advisors (GP) LLC | 25.30% | 43,151,054 |
| Julian C. Baker | 25.40% | 43,294,373 |
| Felix J. Baker | 25.40% | 43,294,373 |
| FBB3 LLC | 0.02% | 40,443 |
Source
Related
- Acadia Pharmaceuticals Inc.
- Baker Julian
- Acadia Pharmaceuticals Inc. shareholders
- Form 4 · Schneyer Mark C. · Aug 7, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Thompson Elizabeth H.Z. · Jul 31, 2026
- Form 4 · Kihara James · Jun 29, 2026
- Form 4 · Baker Brothers Life Sciences LP · Jun 2, 2026